NS

Narayanaswamy Sundareswaran

Director Whole-Time Director DIN 01281262
DIN 01281262 First appointment Jun 2007 Primary industry Chemicals and Materials
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 1 historical roles
Total affiliations 1 Since Jun 2007
Shareholding value β€’β€’β€’β€’ Premium profile

About Narayanaswamy Sundareswaran

Data last updated:

Narayanaswamy Sundareswaran was a Whole-Time Director at Ciphris Bio - Pharma Private Limited (2007–2014). The company operates in Chemicals and Materials.

DIN 01281262
Primary Designation Whole-Time Director
Industry Chemicals and Materials
First Appointment 05 Jun 2007

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ciphris Bio - Pharma Private Limited U24100MH2007PTC171300
Whole-Time Director05 Jun 20072007Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Ciphris Bio - Pharma Private Limited
Premium access

Shareholding and investment profile for Narayanaswamy Sundareswaran

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Narayanaswamy Sundareswaran

Narayanaswamy Sundareswaran was first appointed on 05 Jun 2007 as Whole-Time Director at Ciphris Bio - Pharma Private Limited.

Narayanaswamy Sundareswaran held 1 earlier board appointment: Ciphris Bio - Pharma Private Limited (Whole-Time Director, 05 Jun 2007 to 29 Sep 2014).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available